Table 1. Demographics and clinical characteristics of the study population and univariate relationships with body size metrics.
β values | ||||
---|---|---|---|---|
Variable | N=729 | BMI | WC | WHR |
Age, years | 71.5±9.4 (71, 13) | -0.14† | -0.01 | 0.06 |
Women, n (%) | 441 (60.5) | 0.15† | -0.18† | -0.36† |
BMI, kg/m2 | 27.8±4.6 (27, 6) | - | 0.71† | 0.11† |
WC, cm | 95.2±11.9 (95, 15) | 0.71† | - | 0.60† |
WHR | 0.91±0.08 (0.91, 0.10) | 0.11† | 0.60† | - |
Race-ethnicity | ||||
Caucasians, n (%) | 104 (14.3) | Ref. | Ref. | Ref. |
African-Americans, n (%) | 123 (16.9) | 0.12* | 0.03 | -0.04 |
Hispanics, n (%) | 488 (66.9) | 0.20† | 0.06 | 0.002 |
Other, n (%) | 14 (1.9) | 0.02 | -0.02 | -0.02 |
Systolic BP, mmHg | 135.2±16.7 (134, 22) | 0.16† | 0.13† | 0.06 |
Diastolic BP, mmHg | 78.2±9.4 (79, 14) | 0.18† | 0.17† | 0.09* |
Hypertension, n (%) | 569 (78.1) | 0.18† | 0.18† | 0.11† |
Anti-hypertensive medications, n (%) | 515 (70.6) | 0.18† | 0.18† | 0.10† |
Diabetes mellitus, n (%) | 205 (28.1) | 0.14† | 0.15† | 0.08* |
Hypercholesterolemia, n (%) | 483 (66.3) | 0.06 | 0.03 | 0.02 |
Cholesterol-lowering medications, n (%) | 361 (49.5) | 0.07 | 0.06 | 0.02 |
Coronary artery disease, n (%) | 48 (6.6) | 0.05 | 0.10† | 0.07* |
Cigarette smoking, n (%) | 388 (53.2) | -0.09* | 0.05 | 0.10† |
High school education, n (%) | 335 (46.0) | -0.11† | -0.06 | -0.09* |
Values in table are mean ± SD (median, interquartile range) for continuous variables, numerosity (percent) for proportions, and standardized coefficients (β) from linear regressions.
p<0.05.
p<0.01. BMI: Body mass index. WC: Waist circumference. WHR: Waist-to-hip ratio. BP: Blood pressure.